Hemostatic Dressing Using Kaolin-Chitosan Composite
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hemostatic dressings are inadequate in controlling bleeding, particularly in severe trauma cases, as they often require frequent changes, cause pain due to adhesion issues, and may lead to complications such as intraarterial clots from kaolin particles.
Innovation Solution
A composition combining chamomile, nettle, kaolin, chitosan, fibrinogen, and thrombin with a biocompatible polymer, which synergistically reduces clotting time and blood loss without antiseptic property loss, adhering only to the wound and being non-perishable, durable, and inexpensive.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard hemostatic dressings are used, then bleeding control is achieved to some extent, but bleeding continues for several minutes after application and frequent dressing changes are required
Solution Approach 1:
The invention uses a composite material comprising kaolin particles embedded in a chitosan matrix. This composite structure allows the kaolin to activate the contact pathway of coagulation while the chitosan provides structural integrity and promotes platelet aggregation, achieving rapid and reliable hemostasis within seconds to minutes rather than several minutes
Solution Approach 2:
The invention changes the physical and chemical parameters of the hemostatic agent by using nanoscale kaolin particles (1-100 nm) which have high surface area to volume ratio, enhancing their ability to activate coagulation factors. The chitosan matrix is formulated with specific molecular weight and degree of deacetylation to optimize both hemostatic activity and mechanical properties
2Reliability
If kaolin-based dressings like WoundStat are used, then coagulation is facilitated, but kaolin particles can break loose and drift into veins and arteries causing deadly clots
Solution Approach 1:
The invention embeds kaolin particles within a chitosan matrix, creating a composite material where the kaolin remains contained and cannot break loose into the bloodstream. The chitosan matrix acts as a containment structure that releases kaolin's coagulation-facilitating properties locally at the wound site without allowing systemic circulation of free kaolin particles
Solution Approach 2:
The chitosan matrix serves as an intermediary between the kaolin particles and the biological system. It mediates the release of coagulation factors while preventing direct contact between free kaolin particles and the bloodstream, thus eliminating the harmful effect of intraarterial and intravascular clots
3Ease of operation
If typical dressings are prepared from materials with adhesive properties, then dressing application and removal are facilitated, but the dressings adhere to the injured surface causing significant pain
Solution Approach 1:
The invention applies adhesive properties locally only at the wound contact surface through the chitosan material, which naturally adheres to wound beds. The rest of the dressing structure remains non-adhesive, allowing painless removal while maintaining secure attachment where needed. Chitosan's adhesive quality is inherent to its polycationic structure that binds to negatively charged wound tissue
4Reliability
If hemostatic dressings with modest activity are used, then initial bleeding control is achieved, but the dressings need to be changed frequently exacerbating adhesion problems
Solution Approach 1:
The composite of kaolin and chitosan provides sustained hemostatic activity by simultaneously activating multiple coagulation pathways (contact pathway via kaolin and platelet aggregation via chitosan). This dual-mechanism approach ensures prolonged effectiveness without requiring frequent dressing changes, addressing both the reliability and duration requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively controls hemorrhage from arterial, venous, and soft tissue bleeding, reducing morbidity and mortality by rapidly inducing clotting, minimizing blood loss, and preventing complications like hypothermia and sepsis, while being flexible and non-reactive.
Implementation Method 1
kaolin has been known for decades to activate blood clotting. It is a naturally occurring layered silicate mineral
Implementation Method 2
chitosan—a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit)—is known to facilitate rapid blood clotting
Implementation Method 3
The net result of the cascade is an assembly of the globular protein fibrinogen, which is catalyzed by a second protein, thrombin, to yield chains of fibrin
Implementation Method 4
compositions comprising chamomile, dioecious nettle, kaolin, chitosan, fibrinogen, thrombin components and a biocompatible polymer
Data Source
AI summary
The present invention provides hemostatic compositions comprising components of the flowers of pharmaceutical chamomile (Chamomilla recutita), the leaves of dioecious nettle (Urtica dioica), kaolin, chitosan, fibrinogen and thrombin. Further inclusion of a biocompatible polymeric base, particularly an alignate, generates a composition with superior and broad spectrum hemostatic capabilities, including the ability to arrest arterial hemorrhage. The invention further provides methods of using the inventive compositions in to reduce or stop bleeding, as well as a variety of apparatuses useful in hemostatic contexts that incorporate the inventive compositions. In one particular embodiment, the invention provides hemostatic dressings in which a polymeric layer incorporating chamomile, nettle, kaolin, chitosan, fibrinogen and thrombin components is applied to a textile or fabric material, for example a non-woven viscose.